Mucosan Max with Acetaminophen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including nasal congestion, cough, minor aches and pains, sore throat, headache, and fever reduction. Additionally, it aids in loosening phlegm (mucus) and thinning bronchial secretions, facilitating the clearance of mucus from the bronchial passageways and enhancing the productivity of coughs.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults and children aged 12 years and older is 20 mL administered every 4 hours as needed. It is imperative that no more than 4 doses are taken within a 24-hour period. This product is not intended for use in children under 12 years of age.

Healthcare professionals should instruct patients to measure the dosage using the dosing cup provided with the product, ensuring accurate dosing. The dosing cup should be kept with the product to facilitate proper measurement.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• Concurrent use with prescription monoamine oxidase inhibitors (MAOIs), which are utilized for the treatment of depression, psychiatric or emotional conditions, or Parkinson's disease, is contraindicated. This includes a prohibition on use for 2 weeks following the discontinuation of an MAOI. If there is uncertainty about whether a prescription medication contains an MAOI, a healthcare professional should be consulted prior to using this product.

Warnings and Precautions

This product contains acetaminophen, which carries a significant risk of liver damage if not used according to the specified guidelines. Healthcare professionals should advise patients that severe liver damage may occur if they exceed 4 doses (20 mL each) within a 24-hour period, which is the maximum daily amount for this product. Additionally, patients should be cautioned against using this product in conjunction with other medications containing acetaminophen or consuming three or more alcoholic drinks daily while using this product.

Acetaminophen may also lead to severe skin reactions. Symptoms of such reactions can include skin reddening, blisters, and rash. In the event of a skin reaction, patients must be instructed to discontinue use immediately and seek medical assistance.

Healthcare professionals should be vigilant regarding patients presenting with a sore throat. If the sore throat is severe, persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, it is imperative to consult a physician promptly.

Patients should be advised to stop use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within seven days or are accompanied by fever, or if a cough recurs or occurs with fever, rash, or persistent headache, medical advice should be sought. A worsening fever lasting more than three days, the presence of redness or swelling, or the emergence of new symptoms should also prompt immediate medical consultation, as these may indicate a serious condition.

In cases of severe skin reactions, patients must seek emergency medical help without delay.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions.

Severe liver damage may occur if patients exceed the maximum daily dosage of 4 doses (20 mL each) within a 24-hour period, take this product in conjunction with other medications containing acetaminophen, or consume 3 or more alcoholic drinks daily while using this product. In the event of an overdose, which may result from taking more than the recommended dose, patients should seek immediate medical assistance or contact a Poison Control Center, as prompt medical attention is critical even if no signs or symptoms are initially present.

Patients should also be alert to the possibility of severe skin reactions associated with acetaminophen, which may manifest as skin reddening, blisters, or rash. If any of these symptoms occur, patients are advised to discontinue use and seek medical help immediately.

In cases of severe sore throat that persists for more than 2 days or is accompanied by fever, headache, rash, nausea, or vomiting, patients should consult a doctor promptly. Additionally, patients are advised to stop use and consult a healthcare professional if they experience nervousness, dizziness, sleeplessness, or if symptoms do not improve within 7 days or worsen, particularly if accompanied by fever. Other concerning signs include a worsening fever lasting more than 3 days, the presence of redness or swelling, or the emergence of new symptoms, which could indicate a serious condition.

Patients with specific health conditions should consult a doctor before using this product. These conditions include liver disease, heart disease, high blood pressure, thyroid disease, diabetes, chronic breathing problems (such as chronic bronchitis), persistent or chronic cough (including those associated with smoking, asthma, chronic bronchitis, or emphysema), cough with excessive phlegm, or difficulty urinating due to an enlarged prostate gland.

Furthermore, patients taking the blood-thinning medication warfarin should seek advice from a doctor or pharmacist prior to use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mucosan Max with Acetaminophen (acetaminophen, dextromethorphan hydrobromide, guaifenesin and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

This adult strength product is not intended for use in pediatric patients under 12 years of age. For patients aged 12 years and older, the recommended dosage is 20 mL every 4 hours. There are no established dosing guidelines or safety data for children under 12 years, and therefore, use in this population is contraindicated.

Geriatric Use

Elderly patients, particularly those aged 65 and older, should exercise caution when using this adult strength product, which is not intended for use in children under 12 years of age. Prior to administration, it is advisable for geriatric patients to consult a healthcare provider if they have a history of liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or respiratory conditions such as chronic bronchitis, asthma, or emphysema.

Additionally, patients experiencing persistent or chronic cough, especially those associated with excessive mucus production, or difficulties in urination due to an enlarged prostate gland should seek medical advice before use. Monitoring for potential adverse effects and considering dose modifications may be necessary in this population to ensure safety and efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular assessment of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, as it contains acetaminophen, which poses a risk of severe liver damage. It is critical that patients do not exceed the maximum daily dosage of 4 doses (20 mL each) within a 24-hour period.

Additionally, patients with compromised liver function should avoid concomitant use of other medications containing acetaminophen, as this can further increase the risk of liver injury. Consumption of 3 or more alcoholic drinks daily while using this product is also contraindicated, as it may exacerbate the potential for severe liver damage.

Healthcare providers should assess liver function and consider these factors when prescribing this product to patients with hepatic impairment to ensure safe and effective use.

Overdosage

Taking more than the recommended dose of this product may lead to serious health consequences, particularly liver damage. In the event of an overdose, it is imperative to seek medical assistance immediately or contact a Poison Control Center. Prompt medical intervention is crucial, even if the individual does not exhibit any immediate signs or symptoms of overdose.

Severe liver damage can occur if an individual consumes more than four doses (20 mL each) within a 24-hour period, which exceeds the maximum daily dosage for this product. Healthcare professionals should be vigilant in monitoring patients for any signs of liver impairment and provide appropriate management based on clinical presentation and laboratory findings.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Reports from postmarketing surveillance have identified severe skin reactions associated with acetaminophen use. Symptoms may include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use and seek immediate medical assistance.

Additionally, there have been warnings regarding the potential for liver damage resulting from the ingestion of doses exceeding the recommended amount. In cases of overdose, prompt medical attention is essential, and individuals should contact a Poison Control Center, even if no signs or symptoms are present.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be instructed not to use this product in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult a doctor or pharmacist.

It is important to inform patients that they should not use this product if they are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. Patients should be advised to seek clarification from their healthcare provider if they are unsure whether their prescription medication contains an MAOI.

Patients should be instructed to discontinue use and consult a doctor if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, they should be advised to stop using the product and seek medical advice if their symptoms do not improve within seven days or if they are accompanied by fever. Patients should also be informed to stop use and consult a doctor if a cough returns or occurs with fever, rash, or a persistent headache, or if fever worsens or lasts more than three days. They should be made aware that redness or swelling, as well as the emergence of new symptoms, may indicate a serious condition, warranting immediate medical consultation.

When using this product, patients should be reminded to adhere strictly to the recommended dosage and not exceed the directed amount. It is essential for patients to consult a doctor before use if they have any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or breathing problems such as chronic bronchitis. Patients with a persistent or chronic cough, particularly those associated with smoking, asthma, chronic bronchitis, or emphysema, should also seek medical advice prior to use. Furthermore, patients should be advised to consult a doctor if they have a cough that produces excessive phlegm or if they experience difficulty urinating due to an enlarged prostate gland. Lastly, patients taking the blood-thinning medication warfarin should be encouraged to discuss their use of this product with a doctor or pharmacist.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It is essential to store the product at a temperature range of 15-30°C (59-86°F). Refrigeration is not recommended, as the product should not be exposed to temperatures outside this specified range. Proper handling and storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mucosan Max with Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)